Annual report
4409.TEDINET S100W3CH
Period2024-04-01 → 2025-03-31
Filed2025-06-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥53.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥50.6bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥55.4bn | 2022-04-01 → 2023-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥49.9bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥40.6bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥1.8bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥771m | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥1.8bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥743m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.2bn | 2022-04-01 → 2023-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.9bn | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.4bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.0bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥722m | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.5bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥546m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥977m | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.4bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.0bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.5bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥543m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥67.9bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥69.9bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥68.0bn | at 2023-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥66.5bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥58.4bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥46.8bn | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥50.8bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥21.1bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥19.2bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥17.8bn | at 2023-03-31d | Cons. | Net assets |
| Net assets / equity | ¥16.9bn | at 2022-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥15.1bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.9bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.8bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.7bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.6bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.9bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.3bn | at 2022-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥9.1bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥3.3bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.4bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.7bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥572m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.5bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥2.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.9bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥4.6bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥4.5bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.3bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥1.9bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥900m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.4bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥3.1bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.1bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥73.42 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥25.99 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.31 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥65.43 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥47.12 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥998.18 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥907.5 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥841.15 | at 2023-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥788.43 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥705.36 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 30.9% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 27.3% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.0% | at 2023-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.3% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.8% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 7.7% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 3.0% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.7% | 2022-04-01 → 2023-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.8% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.0% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 866 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 868 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 872 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 855 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 840 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥49.6bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥47.2bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥51.6bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥45.6bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥37.7bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.1bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥705m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥1.2bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥647m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.4bn | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.3bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.2bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.4bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥626m | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥1.2bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥484m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥1.2bn | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.1bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥930m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥63.0bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥65.1bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥63.0bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥61.4bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥54.5bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥46.5bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥48.7bn | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥16.5bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥16.4bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥15.4bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥14.8bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥13.6bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥3.2bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥3.8bn | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥56.71 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.03 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥58.15 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥52.52 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.65 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥20 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥17 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥15 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥15 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥15 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥785.68 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥778.75 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥733.12 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥695.33 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥639.92 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 26.2% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.2% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 24.5% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 24.1% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.0% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 7.2% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.0% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.1% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.9% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.2% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 21,350,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 21,350,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 21,350,000 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 21,350,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 21,350,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 672 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 677 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 685 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 671 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 661 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 62
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2025-03-31 | 8 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2025-03-31 | ¥261m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2025-03-31 | ¥144m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥116m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2025-03-31 | ¥9m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2025-03-31 | −¥116m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2025-03-31 | −¥116m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥58m |
| Industrial Chemicalsreportable segment | employees | at 2025-03-31 | 127 pure |
| Industrial Chemicalsreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥6.6bn |
| Industrial Chemicalsreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥6.6bn |
| Industrial Chemicalsreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥79m |
| Resinsreportable segment | employees | at 2025-03-31 | 77 pure |
| Resinsreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥4.8bn |
| Resinsreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥4.8bn |
| Resinsreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥93m |
| Specialty Chemicalsreportable segment | employees | at 2025-03-31 | 213 pure |
| Specialty Chemicalsreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥15.8bn |
| Specialty Chemicalsreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥15.8bn |
| Specialty Chemicalsreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥954m |
| Surfactantsreportable segment | employees | at 2025-03-31 | 410 pure |
| Surfactantsreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥26.3bn |
| Surfactantsreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥26.3bn |
| Surfactantsreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥737m |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥53.5bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥53.5bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥1.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2025-03-31 | ¥53.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2025-03-31 | ¥53.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥116m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2025-03-31 | ¥1.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2024-03-31 | ¥243m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2024-03-31 | ¥125m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥118m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2024-03-31 | ¥6m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2024-03-31 | −¥118m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2024-03-31 | −¥118m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2024-03-31 | −¥80m |
| Industrial Chemicalsreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥5.9bn |
| Industrial Chemicalsreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥5.9bn |
| Industrial Chemicalsreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥9m |
| Resinsreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥4.0bn |
| Resinsreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥4.0bn |
| Resinsreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥0 |
| Specialty Chemicalsreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥13.0bn |
| Specialty Chemicalsreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥13.0bn |
| Specialty Chemicalsreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥407m |
| Surfactantsreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥27.6bn |
| Surfactantsreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥27.6bn |
| Surfactantsreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥427m |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥50.5bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥50.5bn |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | ¥844m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2024-03-31 | ¥50.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2024-03-31 | ¥50.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥118m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2024-03-31 | ¥851m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2025-03-31 | 0 pure |
| Industrial Chemicalsreportable segment | employees | at 2025-03-31 | 75 pure |
| Resinsreportable segment | employees | at 2025-03-31 | 63 pure |
| Specialty Chemicalsreportable segment | employees | at 2025-03-31 | 208 pure |
| Surfactantsreportable segment | employees | at 2025-03-31 | 295 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,717
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of voting rights issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 322000 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 210233 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 21023300 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember | 4700 | |
| Number of shares issued shares voting rights | CurrentYearInstant | 21350000 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant | 210233 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant_Row1Member | 322000 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant_Row1Member | 322000 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant_Row1Member | 0.0150 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant | 322000 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant | 322000 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant | 0.0150 | |
| Dividend per share dividends of surplus | FilingDateInstant_Row3Member | 20 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row4Member | 420000000 | JPY |
| Number of male directors and other officers | FilingDateInstant | 13 | |
| Number of female directors and other officers | FilingDateInstant | － | |
| Ratio of female directors and other officers | FilingDateInstant | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00886-000NakazakiTatsuoMember | 2528000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00886-000NagaokaMikihitoMember | 17000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00886-000WakitaMasamotoMember | 28000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00886-000NakanoKennichiMember | 12000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00886-000ShimodaHaruhisaMember | 17000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00886-000IkedaAkiraMember | 17000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00886-000KawasakiShoichiMember | 6000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00886-000KoshisakaSeiichiMember | 7000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00886-000AyabeShujiMember | 5000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00886-000KawagoeHiromitsuMember | 1000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00886-000TanakaYoshioMember | 14000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00886-000SekiTakashiMember | 0 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00886-000MiuraYoshimiMember | 1000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant | 2659000 | |
| Number of male directors and other officers proposal | FilingDateInstant | 13 | |
| Number of female directors and other officers proposal | FilingDateInstant | － | |
| Ratio of female directors and other officers proposal | FilingDateInstant | － | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00886-000NakazakiTatsuoMember | 2528 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00886-000NagaokaMikihitoMember | 17 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00886-000WakitaMasamotoMember | 28 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00886-000NakanoKennichiMember | 12 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00886-000ShimodaHaruhisaMember | 17 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00886-000IkedaAkiraMember | 17 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00886-000KawasakiShoichiMember | 6 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00886-000KoshisakaSeiichiMember | 7 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00886-000AyabeShujiMember | 5 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00886-000KawagoeHiromitsuMember | 1 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00886-000TanakaYoshioMember | 14 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00886-000SekiTakashiMember | 0 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00886-000MiuraYoshimiMember | 1 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |